← All organizations

Travere Therapeutics, Inc.

For profitWebsite ↗

Also known as: Travere Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Dec 1, 2025

Timeline

2010s

Jun 1, 2011
Travere Therapeutics, Inc.— Founded

Drugs by trial phase (2 distinct, 9 trials)

Phase 4 (1 own, 0 via acquisition)

sparsentan

Phase 3 (1 own, 0 via acquisition)

ot-58

Indications

Studied for

Recent trials (13)

NCT07224776CollaboratorPhase 1Dec 1, 2025
NCT07219121Lead sponsorPhase 4Oct 7, 2025
NCT06431893OfficialPhase 3Apr 30, 2024
NCT06431893Lead sponsorPhase 3Apr 30, 2024
NCT06247085OfficialPhase 3Dec 28, 2023
NCT06247085Lead sponsorPhase 3Dec 28, 2023
NCT05856760Lead sponsorPhase 2May 19, 2023
NCT05856760Study directorPhase 2May 19, 2023
NCT05630612CollaboratorPhase 2Dec 1, 2022
NCT05003986Study directorPhase 2Aug 12, 2021
NCT05003986Lead sponsorPhase 2Aug 12, 2021
NCT04663204CollaboratorPhase 2Dec 10, 2020
NCT05562362Lead sponsorPhase 1Jun 18, 2020

Details

Founded: San Diego, CA, US Jun 1, 2011
Last known activity: Dec 1, 2025